506U78 in Treating Patients With Recurrent or Refractory Cutaneous T-cell Lymphoma

NCT00005982 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

35

Enrollment

NIH

Sponsor class

Stopped Administratively complete.

Conditions

Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma
Recurrent Mycosis Fungoides/Sezary Syndrome

Interventions

DRUG: nelarabine
OTHER: pharmacological study

Sponsor

National Cancer Institute (NCI)